News
There’s Always Something New at Innovize
Innovize will share recent news, happenings and helpful articles on an ongoing basis.
Innovize’s Supply Chain: Navigating Challenges and Building Strong Relationships
At Innovize, we take pride in our role as a medical device contract manufacturer specializing in stick-to-skin applications. But we [...]
Congratulations to our Q4 2022 Ascending Associates!
At Innovize, we have outstanding associates that are passionate about our purpose of creating a culture and products that improve [...]
Culture in Action: Associate Stories
Innovize talks a pretty big game when it comes to our culture. But how does anyone outside of our company [...]
The Story Behind Consiliso
If you’re familiar with Innovize, you’ve probably heard of our VP of Quality, Mark Rutkiewicz, who quite literally wrote the [...]
OPERATORS NEEDED! Claim your $2,000!
Innovize is an inclusive, diverse, and growing company that needs help creating products that improve people’s lives. We have several [...]
Innovize joins Excel Scientific, Strengthening Vance Street Capital’s Advanced MedTech and Life Sciences Materials and Contract Manufacturing Platform GalleryInnovize joins Excel Scientific, Strengthening Vance Street Capital’s Advanced MedTech and Life Sciences Materials and Contract Manufacturing Platform
Innovize joins Excel Scientific, Strengthening Vance Street Capital’s Advanced MedTech and Life Sciences Materials and Contract Manufacturing Platform
Los Angeles, CA – November 28, 2022 – Vance Street Capital LLC (“Vance Street”) has completed the acquisition of Innovize, [...]
Congratulations to our Q3 2022 Ascending Associates!
At Innovize, we have outstanding associates that are passionate about our purpose of creating a culture and products that improve [...]
Innovize Partners with Epicore Biosystems and 3M on Innovative Sweat Sensors
A recent press release highlighted a partnership between Epicore Biosystems, an impressive wearable microfluidic solutions company, stick-to-skin material powerhouse, 3M, [...]
